摘要
A non-invasive method to distinguish potential lung cancer patients would improve lung cancer prevention. We employed the RNA-sequencing analysis to profile serum exosomal long non-coding RNAs (lncRNAs) from non-small cell lung cancer (NSCLC) patients and pneumonia controls, and then determined the diagnostic and prognostic value of a promising lncRNA in four datasets. We identified 90 dysregulated lncRNAs for NSCLC and found the most significant lncRNA was a novel isoform of linc01125. Serum exosomal linc01125 could distinguish NSCLC cases from disease-free and tuberculosis controls, with the area under the curve values as 0.662 [95% confidence interval (CI) = 0.614-0.7111 and 0.624 (95% CI = 0.522-0.725), respectively. High expression of exosomal linc01125 was also correlated with an unfavorable overall survival of NSCLC (hazard ratio = 1.48, 95% CI = 1.05-2.08). Clinic treatment decreased serum exosomal linc01125 in NSCLC patients (P = 0.036). Linc01125 functions to inhibit cancer growth and metastasis via acting as a competing endogenous RNA to up-regulate tumor necrosis factor alpha-induced protein 3 (TNFAIP3) expression by sponging miR-19b-3p. Notably, the oncogenic transformation of 16HBE led to decreased linc01125 in cells but increased linc01125 in cell-derived exosomes. The expression of linc01125 in total exosomes was highly correlated with that in tumor-associated exosomes in serum. Moreover, lung cancer cells were capable of releasing linc01125 into exosomes in vitro and in vivo. Our analyses suggest serum exosomal linc01125 as a promising biomarker for non-invasively diagnosing NSCLC and predicting the prognosis of NSCLC.
学科与关键词
- Exosomal LncRNA RP5-977B1 as a novel minimally invasive biomarker for diagnosis and prognosis in non-small cell lung cancerMin, Ling; Zhu, Ting; Lv, Bo; An, Taixue; Zhang, Qichao; Shang, Yanyan; Yu, Zhiwu; Zheng, Lei; Wang, Qian*International Journal of Clinical Oncology, 2022, 27(6): 1013-1024.被引 15
- CircFOXP1: A novel serum diagnostic biomarker for non-small cell lung cancerLuo, Yirong; Zhang, Qichao; Lv, Bo; Shang, Yanyan; Li, Juan; Yang, Lina; Yu, Zhiwu; Luo, Kai; Deng, Xiaoyan; Min, Ling; Zhu, Ting*INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2022, 37(1): 58-65.被引 8
- LncRNA RP11-58O9.2 predicts poor prognosis and promotes progression of non-small cell lung cancerMiao, Xuan; Xi, Wen; Bao, Yongxia*Journal of International Medical Research, 2023, 51(10): 03000605231206295.
